Related Experiment Video
Updated: Jul 4, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Disposition kinetics and effects of menthol.
1San Francisco General Hospital Medical Center and the Department of Medicine, Unviersity of California, 94143-1220, USA.
Menthol disposition kinetics and effects were studied. Pure menthol and menthol in food/beverages show similar bioavailability, with menthol causing a slight heart rate increase and reduced vigor.
Area of Science:
- Pharmacology
- Clinical Pharmacology
- Metabolism Studies
Background:
- Menthol is prevalent in consumer products but its clinical pharmacology remains understudied.
- Limited data exists on menthol's disposition kinetics and physiological effects.
- A need for a reliable assay to measure menthol in biological fluids was identified.
Purpose of the Study:
- To investigate the disposition kinetics of menthol.
- To examine the subjective and cardiovascular effects of menthol.
- To develop and utilize a novel assay for menthol measurement.
Main Methods:
- A crossover, placebo-controlled study involving 12 subjects.
- Administration of 100 mg l-menthol capsules, placebo capsules, and 10 mg menthol in food/beverage.
- Measurement of plasma/urine menthol and glucuronide levels, cardiovascular parameters, and subjective effects.
Main Results:
- Menthol was rapidly metabolized to menthol glucuronide, the primary measurable metabolite.
- Plasma half-life of menthol glucuronide differed significantly between capsule and food/beverage forms (P < .05).
- Menthol administration resulted in a less pronounced decrease in heart rate compared to placebo and reduced subjective vigor.
Conclusions:
- Systemic bioavailability of pure menthol and menthol in food/beverages is comparable.
- Menthol exhibits a mild cardioaccelerating effect.
- Further research into menthol's clinical pharmacology is warranted.
Related Concept Videos
Directing and Steric Effects in Disubstituted Benzene Derivatives
Cholinergic Antagonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Nonlinear Pharmacokinetics: Michaelis-Menten Equation
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

